A gene-expression signature to predict survival in breast cancer across independent data sets
暂无分享,去创建一个
I. Ellis | C. Caldas | S. Aparicio | A. Green | S. Pinder | J. Brenton | A. Teschendorff | D. Powe | N. Barbosa-Morais | A. Naderi | S. Pinder | A. Green | J. Robertson | J. Robertson | N. I. Barbosa-Morais | A. Green
[1] Anders Krogh,et al. Learning with ensembles: How overfitting can be useful , 1995, NIPS.
[2] David S. Touretzky,et al. Learning with Ensembles: How Over--tting Can Be Useful , 1996 .
[3] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[4] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[6] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Carlos Caldas,et al. Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling , 2004, BMC Genomics.
[8] R. Lempicki,et al. Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.
[9] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[10] M. Fernö,et al. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. , 2004, European journal of cancer.
[11] R. Tibshirani,et al. Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.
[12] P. Royston,et al. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials , 2004, Statistics in medicine.
[13] Marie-Christine Rio,et al. Association of the Breast Cancer Protein MLN51 with the Exon Junction Complex via Its Speckle Localizer and RNA Binding Module* , 2004, Journal of Biological Chemistry.
[14] Debashis Ghosh,et al. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data , 2004, BMC Genomics.
[15] Patrick Royston,et al. A new measure of prognostic separation in survival data , 2004, Statistics in medicine.
[16] L. Holmberg,et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts , 2005, Breast Cancer Research.
[17] Yudong D. He,et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. , 2005, Cancer research.
[18] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[19] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Caldas,et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Eytan Domany,et al. Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.
[23] John Quackenbush,et al. Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.
[24] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[25] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[26] C. Caldas,et al. Optimal amounts of fluorescent dye improve expression microarray results in tumor specimens , 2005, Molecular biotechnology.